MET — Metlife Cashflow Statement
0.000.00%
Last trade - 00:00
- $51.41bn
- $49.84bn
- $66.91bn
- 61
- 73
- 79
- 82
2019 December 31st | 2020 December 31st | C2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 5,909 | 5,418 | 6,876 | 5,302 | 1,602 |
Depreciation | |||||
Non-Cash Items | 116 | 944 | -1,960 | -685 | 3,697 |
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 7,131 | 4,658 | 6,737 | 7,754 | 7,704 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Gains / Losses on Investment Securities | |||||
Change in Deferred Policy Acquisition Costs | |||||
Change in Reinsurance Receivable | |||||
Change in Insurance Reserves | |||||
Cash from Operating Activities | 13,786 | 11,639 | 12,347 | 13,044 | 13,721 |
Other Investing Cash Flow Items | -17,586 | -18,569 | -11,187 | -2,620 | -10,246 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Policy Loans | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -17,586 | -18,569 | -11,187 | -2,620 | -10,246 |
Financing Cash Flow Items | 6,246 | 8,366 | 4,268 | 5,013 | 4,498 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 4,568 | 10,729 | -1,126 | -9,948 | -2,940 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 777 | 3,962 | -444 | 79 | 444 |